|
NUP210 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.014600E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.47630000446597E-08 |
| Normal-vs-Stage2 |
8.964300E-03 |
| Normal-vs-Stage3 |
5.075000E-03 |
| Normal-vs-Stage4 |
5.467800E-01 |
| Stage1-vs-Stage2 |
3.056600E-01 |
| Stage1-vs-Stage3 |
1.145200E-01 |
| Stage1-vs-Stage4 |
6.069800E-02 |
| Stage2-vs-Stage3 |
8.553000E-01 |
| Stage2-vs-Stage4 |
1.417570E-01 |
| Stage3-vs-Stage4 |
1.568990E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.572100E-04 |
| Normal-vs-AfricanAmerican |
9.657500E-02 |
| Normal-vs-Asian |
3.569600E-01 |
| Caucasian-vs-AfricanAmerican |
6.427600E-01 |
| Caucasian-vs-Asian |
4.998300E-02 |
| AfricanAmerican-vs-Asian |
2.404200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.32820000004119E-06 |
| Normal-vs-Female |
2.827400E-01 |
| Male-vs-Female |
3.056600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.742600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.184000E-02 |
| Normal-vs-Age(61-80Yrs) |
4.790700E-04 |
| Normal-vs-Age(81-100Yrs) |
4.82989999994743E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.015600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.827800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.262030E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.365600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.284200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.821650E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.027540E-02 |
| Normal-vs-Grade 2 |
2.65329980209117E-10 |
| Normal-vs-Grade 3 |
2.871200E-01 |
| Normal-vs-Grade 4 |
6.123200E-01 |
| Grade 1-vs-Grade 2 |
5.520800E-01 |
| Grade 1-vs-Grade 3 |
3.098600E-01 |
| Grade 1-vs-Grade 4 |
3.940100E-02 |
| Grade 2-vs-Grade 3 |
2.208400E-02 |
| Grade 2-vs-Grade 4 |
3.760900E-04 |
| Grade 3-vs-Grade 4 |
2.392200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.99200722162641E-16 |
| Normal-vs-ccB subtype |
4.388400E-01 |
| ccA subtype-vs-ccB subtype |
1.57189999905327E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.041000E-04 |
| Normal-vs-N1 |
1.458000E-01 |
| N0-vs-N1 |
3.892200E-02 |
|
|
